<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Emerg Med</journal-id><journal-id journal-id-type="iso-abbrev">Ann Emerg Med</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Annals of emergency medicine</journal-title></journal-title-group><issn pub-type="ppub">0196-0644</issn><issn pub-type="epub">1097-6760</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10091852</article-id><article-id pub-id-type="pmcid-ver">PMC10091852.1</article-id><article-id pub-id-type="pmcaid">10091852</article-id><article-id pub-id-type="pmcaiid">10091852</article-id><article-id pub-id-type="manuscript-id">NIHMS1883481</article-id><article-id pub-id-type="pmid">36669914</article-id><article-id pub-id-type="doi">10.1016/j.annemergmed.2022.11.003</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1883481</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1883481</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association of Prescription Drug Monitoring Programs with Opioid Prescribing and Overdose in Adolescents and Young Adults</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Toce</surname><given-names initials="MS">Michael S</given-names></name><degrees>M.D., M.S.</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Michelson</surname><given-names initials="K">Kenneth</given-names></name><degrees>M.D., M.P.H.</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hudgins</surname><given-names initials="J">Joel</given-names></name><degrees>M.D., M.P.H.</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hadland</surname><given-names initials="SE">Scott E</given-names></name><degrees>M.D., M.P.H, M.S.</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Olson</surname><given-names initials="KL">Karen L</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Monuteaux</surname><given-names initials="MC">Michael C</given-names></name><degrees>ScD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bourgeois</surname><given-names initials="FT">Florence T</given-names></name><degrees>M.D., M.P.H.</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref><xref rid="A5" ref-type="aff">5</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Emergency Medicine, Boston Children&#8217;s Hospital, Boston, MA</aff><aff id="A2"><label>2</label>Harvard Medical Toxicology Program, Boston Children&#8217;s Hospital, Boston, MA</aff><aff id="A3"><label>3</label>Department of Pediatrics, Harvard Medical School, Boston, MA</aff><aff id="A4"><label>4</label>Division of Adolescent and Young Adult Medicine, MassGeneral Hospital for Children, Boston, MA</aff><aff id="A5"><label>5</label>Computational Health Informatics Program (CHIP), Boston Children&#8217;s Hospital, Boston, MA</aff><aff id="A6"><label>6</label>Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program (CHIP), Boston Children&#8217;s Hospital, Boston, MA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Authors&#8217; Contributions:</p><p id="P2">MT, MM, and FB conceived the study. MT obtained funding and drafted the initial manuscript. JH and SH provided substantial expert knowledge. KO, KM, and MM performed data analysis. FB provided expert supervision. All authors contributed substantially to revisions. MT takes responsibility for the study as a whole.</p></fn><corresp id="CR1"><bold>Correspondence to:</bold> Michael S Toce, M.D., M.S., Boston Children&#8217;s Hospital, 300 Longwood Ave, Boston, MA 02115. <email>Michael.toce@childrens.harvard.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P38"><bold>Conflict of Interest Disclosures:</bold> The authors have no conflicts of interest relevant to this article to disclose.</p></fn></author-notes><pub-date pub-type="ppub"><month>4</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>18</day><month>1</month><year>2023</year></pub-date><volume>81</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">433299</issue-id><fpage>429</fpage><lpage>437</lpage><pub-history><event event-type="nihms-submitted"><date><day>06</day><month>04</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 05:25:25.783"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1883481.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background and Objectives:</title><p id="P3">Prescription opioid use is associated with substance-related adverse outcomes among adolescents and young adults through a pathway of prescribing, diversion and misuse, and addiction and overdose. Assessing the impact of current prescription drug monitoring programs (PDMPs) on opioid prescribing and overdoses will further inform strategies to reduce opioid-related harms.</p></sec><sec id="S2"><title>Methods:</title><p id="P4">We performed interrupted time-series analyses to measure the association between state-level implementation of PDMPs with annual opioid prescribing and opioid-related overdoses in adolescents (13&#8211;18 years) and young adults (19&#8211;25 years) between 2008 and 2019. We focused on PDMPs that included mandatory review by providers. Data were obtained from a commercial insurance company.</p></sec><sec id="S3"><title>Results:</title><p id="P5">Among 9,344,504 adolescents and young adults, 1,405,382 (15.0%) had a dispensed opioid prescription and 6,262 (0.1%) received treatment for an opioid-related overdose. Mandated PDMP review was associated with a 4.2% (95% CI, 1.9 to 6.4%) reduction in annual opioid dispensations among adolescents and a 7.8% (95% CI, 4.7 to 10.9%) annual reduction among young adults. For opioid-related overdoses, mandated PDMP review was associated with a 16.1% (95% CI, 3.8 to 26.7) and 15.9% (95% CI, 7.6 to 23.4) reduction in annual opioid overdoses for adolescents and young adults, respectively.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P6">PDMPs were associated with sustained reductions in opioid prescribing and overdoses in adolescents and young adults. While these findings support the value of mandated PDMPs as part of ongoing strategies to reduce opioid overdoses, further study with prospective study designs are needed to fully characterize the impact of these programs.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>